HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
418.19
+28.57 (7.33%)
At close: Jul 28, 2026, 4:00 PM EDT
418.25
+0.06 (0.01%)
After-hours: Jul 28, 2026, 7:57 PM EDT
HCA Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 78,013 | 75,600 | 70,603 | 64,968 | 60,233 | 58,752 | |
Revenue Growth | 7.31% | 7.08% | 8.67% | 7.86% | 2.52% | 14.01% |
Cost of Revenue | 44,795 | 44,226 | 41,925 | 39,389 | 37,056 | 36,260 |
Gross Profit | 33,218 | 31,374 | 28,678 | 25,579 | 23,177 | 22,492 |
Depreciation & Amortization Expenses | 3,674 | 3,523 | 3,312 | 3,077 | 2,969 | 2,853 |
Other Operating Expenses | 17,471 | 15,886 | 14,819 | 12,875 | 11,155 | 9,961 |
Total Operating Expenses | 21,145 | 19,409 | 18,131 | 15,952 | 14,124 | 12,814 |
Operating Income | 12,073 | 11,965 | 10,547 | 9,627 | 9,053 | 9,678 |
Interest Income | 66 | 78 | 23 | 22 | 45 | 113 |
Interest Expense | -2,316 | -2,248 | -2,061 | -1,938 | -1,741 | -1,566 |
Other Non-Operating Income (Expense) | 48 | 37 | 14 | -5 | 1,223 | 1,608 |
Total Non-Operating Income (Expense) | -2,202 | -2,133 | -2,024 | -1,921 | -473 | 155 |
Pretax Income | 9,871 | 9,832 | 8,523 | 7,706 | 8,580 | 9,833 |
Provision for Income Taxes | 2,018 | 2,050 | 1,866 | 1,615 | 1,746 | 2,112 |
Net Income | 7,853 | 7,782 | 6,657 | 6,091 | 6,834 | 7,721 |
Minority Interest in Earnings | 1,013 | 998 | 897 | 849 | 1,191 | 765 |
Net Income to Common | 6,840 | 6,784 | 5,760 | 5,242 | 5,643 | 6,956 |
Net Income Growth | 14.55% | 17.78% | 9.88% | -7.11% | -18.88% | 85.30% |
Shares Outstanding (Basic) | 227 | 236 | 259 | 272 | 290 | 323 |
Shares Outstanding (Diluted) | 229 | 239 | 262 | 276 | 295 | 329 |
Shares Change | -8.96% | -8.52% | -5.28% | -6.19% | -10.37% | -4.32% |
EPS (Basic) | 30.14 | 28.70 | 22.27 | 19.25 | 19.43 | 21.52 |
EPS (Diluted) | 29.87 | 28.33 | 22.00 | 18.97 | 19.15 | 21.16 |
EPS Growth | 25.56% | 28.77% | 15.97% | -0.94% | -9.50% | 93.60% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 5,997 | 7,692 | 5,639 | 4,687 | 4,127 | 5,382 |
Free Cash Flow Growth | -17.76% | 36.41% | 20.31% | 13.57% | -23.32% | -15.87% |
Free Cash Flow Per Share | 26.18 | 32.12 | 21.54 | 16.96 | 14.01 | 16.37 |
Dividends Per Share | 3.000 | 2.880 | 2.640 | 2.400 | 2.240 | 1.920 |
Dividend Growth | 8.70% | 9.09% | 10.00% | 7.14% | 16.67% | 346.51% |
Gross Margin | 42.58% | 41.50% | 40.62% | 39.37% | 38.48% | 38.28% |
Operating Margin | 15.48% | 15.83% | 14.94% | 14.82% | 15.03% | 16.47% |
Profit Margin | 10.07% | 10.29% | 9.43% | 9.38% | 11.35% | 13.14% |
FCF Margin | 7.69% | 10.17% | 7.99% | 7.21% | 6.85% | 9.16% |
EBITDA | 15,747 | 15,488 | 13,859 | 12,704 | 12,022 | 12,531 |
EBITDA Margin | 20.19% | 20.49% | 19.63% | 19.55% | 19.96% | 21.33% |
EBIT | 12,073 | 11,965 | 10,547 | 9,627 | 9,053 | 9,678 |
EBIT Margin | 15.48% | 15.83% | 14.94% | 14.82% | 15.03% | 16.47% |
Effective Tax Rate | 20.44% | 20.85% | 21.89% | 20.96% | 20.35% | 21.48% |